top of page
First Round Structure
INTRA-KER is registered in Italy as innovative startup.
Funds allocation will be split mainly in R&D of clinical trial and startup initial costs.
G&A
5%
HR
5%
MARKETING
5%
R&D
CLINICAL TRIAL
85%
Commitment
received
300K €
TOTAL ROUND REQUIRED 1,5 M€
Key Figures
Coming soon
Investor Relations
For more info about running round please contact us.
Vittorio Guarini +39 339 883 3420
bottom of page